Navigation Links
China Medical Technologies Senior Management Purchased Company Shares
Date:3/6/2009

BEIJING, March 6 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products, today announced that each of Mr. Xiaodong Wu, the Company's Chairman and Chief Executive Officer, Mr. Sam Tsang, the Company's Chief Financial Officer and Dr. Zhong Chen, the Company's Chief Technology Officer, purchased the Company's American Depositary Shares (''ADSs'') in the open market in the past two days.

Mr. Wu purchased 150,000 ADSs at an average price of US$13.07 per ADS. Mr. Tsang purchased 6,500 ADSs at an average price of US$13.15 per ADS. Dr. Chen purchased 5,000 ADSs at an average price of US$12.81 per ADS.

Mr. Wu has indicated to the Company that he may continue to purchase the Company's ADSs in the open market in the future in compliance with the Company's insider trading policy.

About China Medical Technologies, Inc.

China Medical Technologies is a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic (IVD) products using Enhanced Chemiluminescence (ECLIA) technology, Fluorescent in situ Hybridization (FISH) technology and Surface Plasmon Resonance (SPR) technology to detect and monitor various diseases and disorders. For more information, please visit http://www.chinameditech.com .

    For more information, please contact:

     Winnie Yam
     Tel:   +86-10-6530-8833
     Email: IR@chinameditech.com

'/>"/>
SOURCE China Medical Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. China Bio-Immunity Corporation - Rabies Vaccine Recall
2. China Medicine to Participate in 2009 Natural Products Expo West Trade Show
3. China Sky One Medical, Inc. Signs Exclusive Distribution Agreement with Shaanxi Buchang Group for Naftopidil Dispersible Tablets
4. Frontage Laboratories Continues to Grow Its China Business and Add Corporate Financial, Regulatory and Clinical Pharmacology Talent
5. Dow AgroSciences, China National Rice Research Institute Announce Collaboration on Rice Research
6. China Biologic Products High-Purity Human Albumin Research and Development Project to be Listed in the National Torch Plan
7. OriGene Technologies, Inc. Establishes High Throughput Monoclonal Antibody Production Outsourcing Center in China
8. China Biologic Products Receives High-Technology Enterprise Certification to Qualify for Preferential Income Tax Rate
9. China Pharma Holdings, Inc. Announces Clinical Trials Already Underway for Candesartan
10. China-Biotics, Inc. to Present at Roth Capital Partners 21st Annual OC Growth Stock Conference
11. Syngenta Enters Into Research Collaboration With Anhui Academy, China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/9/2017)... ... ... At its national board meeting in North Carolina, ARCS® Foundation President ... and Astronomy, has been selected for membership in ARCS Alumni Hall of Fame ... Prize in Fundamental physics for the discovery of the accelerating expansion of the universe, ...
(Date:10/7/2017)... ... October 06, 2017 , ... ... for microscopy and surface analysis, Nanoscience Instruments is now expanding into Analytical ... broad range of contract analysis services for advanced applications. Services will leverage ...
(Date:10/6/2017)... ... October 06, 2017 , ... ... the healthcare and technology sector at their fourth annual Conference where founders, investors, ... inspiring speakers and the ELEVATE pitch competition showcasing early stage digital health and ...
(Date:10/5/2017)... ... October 05, 2017 , ... Understanding the microbiome, the millions ... human health. Gut Love: You Are My Future, the newest exhibit on display at ... it explores the human condition through the lens of the gut microbiome. , ...
Breaking Biology Technology:
(Date:10/4/2017)... 4, 2017  GCE Solutions, a global clinical research organization (CRO), ... anonymization solution on October 4, 2017. Shadow is designed to assist ... with policy 0070 of the European Medicines Agency (EMA) in meeting ... ... ...
(Date:8/15/2017)... ivWatch LLC , a medical device company focused on improving the ... its ISO 13485 Certification, the global standard for medical device quality ... ... device for the early detection of IV infiltrations. ... "This is an important milestone for ivWatch, as it validates ...
(Date:6/30/2017)... June 30, 2017 Today, American Trucking ... supplier of face and eye tracking software, became ... provider program. "Artificial intelligence and ... to monitor a driver,s attentiveness levels while on ... able to detect fatigue and prevent potential accidents, ...
Breaking Biology News(10 mins):